Liselotte Højgaard joins the Board of the Novo Nordisk Foundation, and Mads Grøn, Anne Marie Kverneland and Lars Bo Køppler have been elected as employee representatives on the Board for the next 4 years.
Liselotte Højgaard has considerable research experience and in-depth insight into Denmark’s healthcare system obtained from leading positions at Rigshospitalet and the University of Copenhagen and as Chair of the Danish National Research Foundation.
Liselotte Højgaard has headed Rigshospitalet’s Department of Clinical Physiology, Nuclear Medicine & PET since 2000 and is Professor of Medical Technology, Faculty of Health Sciences, University of Copenhagen and Adjunct Professor of Advanced Imaging, Technical University of Denmark. As Chair of the Board of the Danish National Research Foundation, she has considerable experience in developing and implementing research programmes. In 2017, she published a book (in Danish) on how to get the world’s best healthcare system.
Liselotte Højgaard joins the Foundation’s Board, filling the vacancy left by Bo Ahrén, who retired in December 2017.
“Liselotte Højgaard is an outstanding researcher, and her background and vast experience as a professor, consultant and clinician are extremely relevant to the Foundation. We look forward to benefiting from her experience and many competencies,” says Sten Scheibye, Chairman of the Board, Novo Nordisk Foundation.
In addition, three employee representatives have been elected to the Board of the Foundation for the next 4 years: Mads Grøn, Auditor, Novo Nordisk A/S; Anne Marie Kverneland, Laboratory Technician and union representative, Novo Nordisk A/S; and Lars Bo Køppler, Technician and union representative, Novozymes A/S.
Anne Marie Kverneland and Lars Bo Køppler have been members of the Board for the past 4 years. Mads Grøn joins the Board for the first time, replacing Désirée Asgreen, Project Director, Novo Nordisk A/S.
“I would like to welcome Mads Grøn to the Board, and I am also very pleased to continue the collaboration with Anne Marie Kverneland and Lars Bo Køppler. I also thank Désirée Asgreen for her excellent and important contributions to the work of the Board,” says Sten Scheibye.
ABOUT LISELOTTE HØJGAARD
2000–: Head of Department, Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet
2006–: Professor of Medical Technology, Faculty of Health Sciences, University of Copenhagen
Selected board appointments
Chair of the Board, Danish National Research Foundation
Partner and Member of the Board of the Trustees, Robert Bosch Stiftung
Member of the Board, Crown Prince Frederik and Crown Princess Mary’s Foundation
1982: MD, University of Copenhagen
1990: Specialist physician in clinical physiology and nuclear medicine, University of Copenhagen
1992: Doctor of Medical Sciences, University of Copenhagen
Has published more than 200 research papers on gastroenterology, pathophysiology, nuclear medicine and PET
ABOUT MADS GRØN
MSc in Biology, University of Copenhagen, 1993
Employed at Novo Nordisk A/S, 2001–2005 and from 2016
ABOUT ANNE MARIE KVERNELAND
Educated as hospital laboratory technician, Rigshospitalet, 1980
Employed at Novo Nordisk A/S since 1981 and now full-time union representative. Employee representative on the Board of the Novo Nordisk Foundation since 2000
ABOUT LARS BO KØPPLER
Graduated as food technician, Danish Meat Trade College, Roskilde, 1993
Employed at Novozymes A/S since 1993. Employee representative on the Board of the Novo Nordisk Foundation since 2000 and union representative for technicians at Novozymes A/S
Christian Mostrup Scheel, Senior Press Officer, Novo Nordisk Foundation,
phone: +45 3067 4805, firstname.lastname@example.org